Literature DB >> 15516475

Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF.

W E Lawson1, S W Grant, V Ambrosini, K E Womble, E P Dawson, K B Lane, C Markin, E Renzoni, P Lympany, A Q Thomas, J Roldan, T A Scott, T S Blackwell, J A Phillips, J E Loyd, R M du Bois.   

Abstract

BACKGROUND: While idiopathic pulmonary fibrosis (IPF) is one of the most common forms of interstitial lung disease, the aetiology of IPF is poorly understood. Familial cases of pulmonary fibrosis suggest a genetic basis for some forms of the disease. Recent reports have linked genetic mutations in surfactant protein C (SFTPC) with familial forms of pulmonary fibrosis, including one large family in which a number of family members were diagnosed with usual interstitial pneumonitis (UIP), the pathological correlate to IPF. Because of this finding in familial cases of pulmonary fibrosis, we searched for SFTPC mutations in a cohort of sporadic cases of UIP and non-specific interstitial pneumonitis (NSIP).
METHODS: The gene for SFTPC was sequenced in 89 patients diagnosed with UIP, 46 patients with NSIP, and 104 normal controls.
RESULTS: Ten single nucleotide polymorphisms in the SFTPC sequence were found in IPF patients and not in controls. Only one of these created an exonic change resulting in a change in amino acid sequence. In this case, a T to C substitution resulted in a change in amino acid 73 of the precursor protein from isoleucine to threonine. Of the remaining polymorphisms, one was in the 5' UTR, two were exonic without predicted amino acid sequence changes, and six were intronic. One intronic mutation suggested a potential enhancement of a splicing site.
CONCLUSIONS: Mutations in SFTPC are identified infrequently in this patient population. These findings indicate that SFTPC mutations do not contribute to the pathogenesis of IPF in the majority of sporadic cases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15516475      PMCID: PMC1746860          DOI: 10.1136/thx.2004.026336

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  17 in total

1.  A mutation in the surfactant protein C gene associated with familial interstitial lung disease.

Authors:  L M Nogee; A E Dunbar; S E Wert; F Askin; A Hamvas; J A Whitsett
Journal:  N Engl J Med       Date:  2001-02-22       Impact factor: 91.245

Review 2.  Splicing regulation as a potential genetic modifier.

Authors:  Malka Nissim-Rafinia; Batsheva Kerem
Journal:  Trends Genet       Date:  2002-03       Impact factor: 11.639

3.  Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms.

Authors:  M Whyte; R Hubbard; R Meliconi; M Whidborne; V Eaton; C Bingle; J Timms; G Duff; A Facchini; A Pacilli; M Fabbri; I Hall; J Britton; I Johnston; F Di Giovine
Journal:  Am J Respir Crit Care Med       Date:  2000-08       Impact factor: 21.405

Review 4.  Hydrophobic surfactant proteins in lung function and disease.

Authors:  Jeffrey A Whitsett; Timothy E Weaver
Journal:  N Engl J Med       Date:  2002-12-26       Impact factor: 91.245

5.  Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis.

Authors:  E Stickeler; F Kittrell; D Medina; S M Berget
Journal:  Oncogene       Date:  1999-06-17       Impact factor: 9.867

6.  Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred.

Authors:  Alan Q Thomas; Kirk Lane; John Phillips; Melissa Prince; Cheryl Markin; Marcy Speer; David A Schwartz; Radhika Gaddipati; Annis Marney; Joyce Johnson; Richard Roberts; Jonathan Haines; Mildred Stahlman; James E Loyd
Journal:  Am J Respir Crit Care Med       Date:  2002-05-01       Impact factor: 21.405

7.  Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland.

Authors:  U Hodgson; T Laitinen; P Tukiainen
Journal:  Thorax       Date:  2002-04       Impact factor: 9.139

8.  Surfactant protein deficiency in familial interstitial lung disease.

Authors:  R S Amin; S E Wert; R P Baughman; J F Tomashefski; L M Nogee; A S Brody; W M Hull; J A Whitsett
Journal:  J Pediatr       Date:  2001-07       Impact factor: 4.406

9.  Synthetic processing of surfactant protein C by alevolar epithelial cells. The COOH terminus of proSP-C is required for post-translational targeting and proteolysis.

Authors:  M F Beers; C A Lomax; S J Russo
Journal:  J Biol Chem       Date:  1998-06-12       Impact factor: 5.157

10.  Pneumonitis and emphysema in sp-C gene targeted mice.

Authors:  Stephan W Glasser; Emily A Detmer; Machiko Ikegami; Cheng-Lun Na; Mildred T Stahlman; Jeffrey A Whitsett
Journal:  J Biol Chem       Date:  2003-01-07       Impact factor: 5.157

View more
  106 in total

Review 1.  Genetic interstitial lung disease.

Authors:  Megan Stuebner Devine; Christine Kim Garcia
Journal:  Clin Chest Med       Date:  2011-12-06       Impact factor: 2.878

Review 2.  Emerging evidence for endoplasmic reticulum stress in the pathogenesis of idiopathic pulmonary fibrosis.

Authors:  Harikrishna Tanjore; Timothy S Blackwell; William E Lawson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-01-27       Impact factor: 5.464

3.  The genetic basis of idiopathic pulmonary fibrosis.

Authors:  Jonathan A Kropski; Timothy S Blackwell; James E Loyd
Journal:  Eur Respir J       Date:  2015-04-02       Impact factor: 16.671

Review 4.  Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapy.

Authors:  Jeffrey C Horowitz; Victor J Thannickal
Journal:  Treat Respir Med       Date:  2006

Review 5.  Mitochondria in the spotlight of aging and idiopathic pulmonary fibrosis.

Authors:  Ana L Mora; Marta Bueno; Mauricio Rojas
Journal:  J Clin Invest       Date:  2017-02-01       Impact factor: 14.808

Review 6.  Genetic predisposition to respiratory diseases: infiltrative lung diseases.

Authors:  Mark P Steele; Kevin K Brown
Journal:  Respiration       Date:  2007       Impact factor: 3.580

7.  Revealing the Secrets of Idiopathic Pulmonary Fibrosis.

Authors:  Richard K Albert; David A Schwartz
Journal:  N Engl J Med       Date:  2019-01-03       Impact factor: 91.245

Review 8.  The molecular era of surfactant biology.

Authors:  Jeffrey A Whitsett
Journal:  Neonatology       Date:  2014-05-30       Impact factor: 4.035

Review 9.  Biomarkers in idiopathic pulmonary fibrosis.

Authors:  Yingze Zhang; Naftali Kaminski
Journal:  Curr Opin Pulm Med       Date:  2012-09       Impact factor: 3.155

Review 10.  New therapeutic targets in idiopathic pulmonary fibrosis. Aiming to rein in runaway wound-healing responses.

Authors:  Neil Ahluwalia; Barry S Shea; Andrew M Tager
Journal:  Am J Respir Crit Care Med       Date:  2014-10-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.